Study title and authors:
Simvastatin interferes with process outgrowth and branching of oligodendrocytes.
Smolders I, Smets I, Maier O, vandeVen M, Steels P, Ameloot M.
Biomedical Research Institute, School of Life Sciences, Hasselt University and Transnational University Limburg, Diepenbeek, Belgium.
This paper can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/20857509
Oligodendrocytes are a type of brain cell. They are the cell type that is predominantly affected in multiple
sclerosis. Myelin is the protective sheath coating our nerve fibers.
sclerosis. Myelin is the protective sheath coating our nerve fibers.Any adverse effects on oligodendrocytes and myelin are detrimental and are implicated in multiple sclerosis.
The study focused on the effects of stain drugs on oligodendrocytes and myelin.
The study found:
(a) Cholesterol is required for the growth of oligodendrocytes.
(b) Statins inhibited the growth of oligodendrocytes.
(c) Statins inhibited the growth of myelin.
To conclude: Statin treatment has detrimental effects on oligodendrocyte growth, which is the prior step in (re)myelination, and thereby inhibits the healing of multiple sclerosis lesions.
No comments:
Post a Comment
I appreciate appropriate comments but reserve the right to publish those with credible, verifiable, significant information to contribute to the topic at hand. I will not post comments with commercial content nor those containing personal attacks. Thank You.